Systemic risk factors for progression of diabetic retinopathy in type 2 diabetes mellitus
Open Access
- 25 May 2025
- journal article
- Published by Publishing House Zaslavsky in Archive of Ukrainian Ophthalmology
- Vol. 13 (1) , 1-5
Abstract
Background. According to the International Diabetes Federation (IDF), the number of adults with diabetes mellitus worldwide reached 537 million in 2021, which is 9.8 % of the world’s population. In Ukraine, according to the IDF, the number of patients with diabetes was 2.35 million people in 2021. It is known that diabetic retinopathy is one of the most severe vascular complications of diabetes and the main cause of blindness, affecting about 40 % of patients. The purpose was to establish the most significant systemic risk factors for the progression of diabetic retinopathy in type 2 diabetes. Materials and methods. An analytical prospective cohort study was conducted with a total of 186 people with type 2 diabetes from the Ukrainian population. They were divided into the following groups according to the condition of the worse eye: the main group — any form of diabetic retinopathy (112 people) and the comparison group — no signs of diabetic retinopathy (74 patients). The inclusion criteria were voluntary informed consent to participate in the study, age over 18 years, presence of verified type 2 diabetes. The type of glucose-lowering therapy was prescribed by an endocrinologist. All patients underwent a standard ophthalmological examination (visometry, refractometry, intraocular pressure and visual field test, gonioscopy, biomicroscopy, ophthalmoscopy, optical coherence tomography, fundus photography). Systemic factors included were blood pressure — systolic and diastolic, glycosylated hemoglobin, blood ferritin and hemoglobin, cholesterol and low-density lipoprotein levels. Statistical analysis of the study results was performed using the licensed software package Statistica v6.1. Results. Most patients with type 2 diabetes in the main group (75.89 %) were diagnosed with a severe form of disease compared to 29.72 % of controls (p < 0.01). Accordingly, 69.64 % of patients in the main group and only 43.24 % of patients with diabetes without manifestations of retinopathy were on insulin therapy (p < 0.05). It was found that the level of glycosylated hemoglobin in the main group was significantly higher than in controls: 8.64 ± 0.62 % versus 6.90 ± 0.21 % (p < 0.05). The levels of hemoglobin, ferritin and cholesterol in the main group were statistically significantly higher than in the control one (p < 0.05). Low-density lipoprotein level did not have a statistically significant difference in both groups (p > 0.05); however, in the main group, the indicator was higher than in controls. Conclusions. The occurrence of diabetic retinopathy depends on the severity of type 2 diabetes. According to our data, 75.89 % of patients with diabetic retinopathy of various stages were diagnosed with a severe form of diabetes compared to 29.72 % of those without manifestations of diabetic retinopathy (p < 0.01). Systemic risk factors for diabetic retinopathy include elevated levels of glycosylated hemoglobin, ferritin, hemoglobin, and blood cholesterol (p < 0.05).Keywords
This publication has 13 references indexed in Scilit:
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045Diabetes Research and Clinical Practice, 2022
- ETDRS Grading of Diabetic Retinopathy: Still the Gold Standard?Ophthalmic Research, 2019
- Study of anemia in diabetes and its association with diabetic retinopathyInternational Journal of Advances in Medicine, 2017
- The Diabetic Retinopathy Barometer Study: Global perspectives on access to and experiences of diabetic retinopathy screening and treatmentDiabetes Research and Clinical Practice, 2017
- Diabetic Retinopathy: A Position Statement by the American Diabetes AssociationDiabetes Care, 2017
- Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 DiabetesDiabetes Care, 2016
- HbA1c, systolic blood pressure variability and diabetic retinopathy in Asian type 2 diabeticsJournal of Diabetes, 2016
- Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a reviewClinical & Experimental Ophthalmology, 2016
- Risk Factors for Retinopathy and DME in Type 2 Diabetes—Results from the German/Austrian DPV DatabasePLOS ONE, 2015
- Association among low whole blood viscosity, haematocrit, haemoglobin and diabetic retinopathy in subjects with type 2 diabetesBritish Journal of Ophthalmology, 2010